A pharmaceutical company in China has experimented Favipiravira, a new drug with hopes of curing Coronavirus.
According to unconfirmed reports, Favipiravir has cured about 80 coronavirus patients in China.
The National Medical Products Administration of China has reportedly given authorization for the mass production of the drug.
Favipiravir is said to be an antiviral drug that has shown good clinical efficacy against the novel coronavirus disease (COVID-19).
Mr. Zhang Xinmin, the director of the China National Center for Biotechnology Development under the Ministry of Science and Technology in China confirmed the report saying,
“Favipiravir has been recommended to medical treatment teams and should be included in the diagnosis and treatment plan for COVID-19 as soon as possible.”